Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial (Zonegran)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00203450

Recruitment Status : Completed

First Posted : September 20, 2005

Last Update Posted : September 3, 2012

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Eisai Inc.

Information provided by (Responsible Party):

Lori Davis, MD, Tuscaloosa Research & Education Advancement Corporation

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	March 2005
Actual Study Completion Date :	March 2006

Publications:

Appolinario JC, Bueno JR, Coutinho W. Psychotropic drugs in the treatment of obesity: what promise? CNS Drugs. 2004;18(10):629-51. doi: 10.2165/00023210-200418100-00002.

To Top